The increased cytotoxic T cells (CD3+ CD8+) in tumors also demonstrated that AH1-aECM could activate the immune response to inhibit tumor growth (Fig. 7e and Supplementary Fig. 18). The gene discussed is CD8A; the disease is neoplasm.